Muscle Warfare a wholly owned subsidiary of Embark Holdings (EMBK) passes inspection by the FDA
WELLINGTON, Fla., May 20, 2013 /PRNewswire/ — Embark Holdings, Inc. (OTC: EMBK) announces that its wholly owned subsidiary Muscle Warfare, Inc. has passed a recent FDA inspection entitled an EIR (Establishment Inspection Report). The inspection was conducted to confirm that Muscle Warfare had discontinued the use of DMAA as stated in a response letter dated back to May of 2012. The inspection also included a complete facility inspection, which reviewed written and executed standard operating procedures including quality control systems. The FDA completed the inspection and filed a report stating there were no deficiencies observed during their inspection.
Nutraingredients.com an industry leading Supplement and Nutrients online magazine released a recent article on May 10, 2013 regarding FDA inspections and warning letters. See the following link: FDA warning letter highlights obligations of private label distributors. With the recent FDA inspections being finalized, Muscle Warfare passed the inspections which demonstrate that the company’s focus to deliver quality products has proven to pay dividends in the way of compliance and quality.
Daniel Amato, President and CEO of Muscle Warfare, Inc. and Embark Holdings, Inc. stated, “I am pleased with the outcome of this EIR (Establishment Inspection Report) as it helps demonstrate Muscle Warfare’s strong commitment to work closely with FDA, but more importantly shows compliance to stay within the industry guidelines, which helps enable us to deliver the highest quality sports nutrition products to the end consumer. With no deficiencies observed during the inspection, this EIR gives a boost to our team moral, displaying proper execution of strict quality control measures and standard operating procedures. Additionally, we will continue to utilize regular HFL Testing of our products to help insure they are free of banned substances or contaminants and may be used by professional and competitive athletes with confidence everywhere.”
About Muscle Warfare, Inc.
Muscle Warfare is a cutting edge sports nutrition manufacturer that is passionately driven to create and distribute the absolute highest quality products in the marketplace. Every product we develop has been forged with great experience and focus on maximizing product efficacy for real world results. Furthermore, Muscle Warfare products are rigorously tested by top testing labs to help insure them free of banned substances. We are truly committed to helping all athletes achieve and surpass their highest goals and potential.
About Embark Holdings, Inc. (OTC: EMBK)
Founded in 1985 and headquartered in Wellington, Florida, United States, our business model is to research, evaluate, and acquire profitable private firms in the business segments of sports nutrition, energy, and business services for the benefit of our shareholders.
By providing the financial and human capital necessary to deal with the overwhelming administrative, planning, governance, compliance, and regulatory issues that abound, our partners can focus their energy and flourish.
Stay up-to-date with current events by joining Embark Holdings, Inc. E-Mail Alert List. Join by going to the following: firstname.lastname@example.org
FORWARD-LOOKING STATEMENT: This press release contains forward-looking statements, including expected industry patterns and other financial and business results that involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. Such risk factors include, among others: the sustainability of recent growth rates in the holding industry; the positioning of Embark Holdings in the market; ability to integrate acquired companies and technology; ability to retain key employees; ability to successfully combine product offerings and customer acceptance of combined products; general market conditions, fluctuations in currency exchange rates, changes to operating systems and product strategy by vendors of operating systems; and whether Embark Holdings can successfully gain market acceptance. Actual results may differ materially from those contained in the forward-looking statements in this press release.
Investor Contact Information:
Phone: (888) 862-1409
Fax: (888) 862-4043
SOURCE Embark Holdings, Inc.